Intra- and Interlaboratory Reproducibility of an ELISA Serological Test for Lyme Disease

by Martin C Tammemagi, John W Frank, Michael LeBlanc, Harvey Artsob
Published 1995-01-01

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

by Martin C Tammemägi, Timothy R Church, William G Hocking, Gerard A Silvestri, Paul A Kvale, Thomas L Riley, John Commins, Christine D Berg
Published 2014-12-01

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

by Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza
Published 2020-09-01

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.

by Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza
Published 2017-04-01

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.

by Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat
Published 2017-02-01

Brief Report: Risk Prediction Model Versus United States Preventive Services Task Force 2020 Draft Lung Cancer Screening Eligibility Criteria—Reducing Race Disparities

by Mary M. Pasquinelli, DNP, Martin C. Tammemägi, PhD, Kevin L. Kovitz, MD, Marianne L. Durham, DNP, Zanë Deliu, MS, Kayleigh Rygalski, BS, Li Liu, PhD, Matthew Koshy, MD, Patricia Finn, MD, Lawrence E. Feldman, MD
Published 2021-03-01

Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population

by John R. Goffin, Gregory R. Pond, Serge Puksa, Alain Tremblay, Michael Johnston, Glen Goss, Garth Nicholas, Simon Martel, Rick Bhatia, Geoffrey Liu, Heidi Schmidt, Sukhinder Atkar-Khattra, Annette McWilliams, Ming-Sound Tsao, Martin C. Tammemagi, Stephen Lam
Published 2020-11-01

Two-Year Follow-Up of a Randomized Controlled Study of Integrated Smoking Cessation in a Lung Cancer Screening Program

by Alain Tremblay, MDCM, Niloofar Taghizadeh, PhD, Paul MacEachern, MD, Paul Burrowes, MD, Andrew J. Graham, MD, Stephen C. Lam, MD, Huiming Yang, MD, Rommy Koetzler, MD, PhD, Martin C. Tammemägi, PhD, Kathryn Taylor, PhD, Eric L.R. Bédard, MD
Published 2021-02-01

Prediction of lung cancer risk at follow-up screening with low-dose CT: a training and validation study of a deep learning method

by Peng Huang, PhD, Cheng T Lin, MD, Yuliang Li, MS, Martin C Tammemagi, ProfPhD, Malcolm V Brock, ProfMD, Sukhinder Atkar-Khattra, BSc, Yanxun Xu, PhD, Ping Hu, ScD, John R Mayo, ProfMD, Heidi Schmidt, ProfMD, Michel Gingras, MD, Sergio Pasian, MD, Lori Stewart, MD, Scott Tsai, MD, Jean M Seely, MD, Daria Manos, MD, Paul Burrowes, MD, Rick Bhatia, MD, Ming-Sound Tsao, ProfMD, Stephen Lam, ProfMD
Published 2019-11-01

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

by Giulia Veronesi, David R. Baldwin, Claudia I. Henschke, Simone Ghislandi, Sergio Iavicoli, Matthijs Oudkerk, Harry J. De Koning, Joseph Shemesh, John K. Field, Javier J. Zulueta, Denis Horgan, Lucia Fiestas Navarrete, Maurizio Valentino Infante, Pierluigi Novellis, Rachael L. Murray, Nir Peled, Cristiano Rampinelli, Gaetano Rocco, Rzyman Witold, Giorgio Vittorio Scagliotti, Martin C. Tammemagi, Luca Bertolaccini, Natthaya Triphuridet, Rowena Yip, Alexia Rossi, Suresh Senan, Giuseppe Ferrante, Kate Brain, Carlijn van der Aalst, Lorenzo Bonomo, Dario Consonni, Jan P. Van Meerbeeck, Patrick Maisonneuve, Silvia Novello, Anand Devaraj, Zaigham Saghir, Giuseppe Pelosi
Published 2020-06-01